Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 7 de 7
Filtrer
1.
Acta Psychiatr Scand ; 121(6): 480-4, 2010 Jun.
Article de Anglais | MEDLINE | ID: mdl-19958307

RÉSUMÉ

OBJECTIVE: In order to evaluate the presence of treatment emergent suicidal ideation (SI), it becomes necessary to identify those patients with SI at the onset of treatment. The purpose of this report is to identify sociodemographic and clinical features that are associated with SI in major depressive disorder (MDD) patients prior to treatment with a selective serotonin reuptake inhibitor. METHOD: This multisite study enrolled 265 out-patients with non-psychotic MDD. Sociodemographic and clinical features of participants with and without SI were compared post hoc. RESULTS: Social phobia, bulimia nervosa, number of past depressive episodes, and race were independently associated with SI by one or more SI measure. CONCLUSION: Concurrent social phobia and bulimia nervosa may be potential risk factors for SI in patients with non-psychotic MDD. Additionally, patients with more than one past depressive episode may also be at increased risk of SI.


Sujet(s)
Boulimie nerveuse/complications , Trouble dépressif majeur , Troubles phobiques/complications , Inbiteurs sélectifs de la recapture de la sérotonine , Tentative de suicide , Adulte , Sujet âgé , Établissements de soins ambulatoires , Antidépresseurs/administration et posologie , Antidépresseurs/effets indésirables , Boulimie nerveuse/diagnostic , Recherche comparative sur l'efficacité , Démographie , Trouble dépressif majeur/complications , Trouble dépressif majeur/diagnostic , Trouble dépressif majeur/traitement médicamenteux , Trouble dépressif majeur/psychologie , Diagnostic and stastistical manual of mental disorders (USA) , Calendrier d'administration des médicaments , Femelle , Humains , Mâle , Adulte d'âge moyen , Troubles phobiques/diagnostic , Échelles d'évaluation en psychiatrie , Facteurs de risque , Prévention secondaire , Inbiteurs sélectifs de la recapture de la sérotonine/administration et posologie , Inbiteurs sélectifs de la recapture de la sérotonine/effets indésirables , Idéation suicidaire , Tentative de suicide/prévention et contrôle , Tentative de suicide/psychologie , États-Unis , Jeune adulte
2.
Psychol Med ; 40(6): 955-65, 2010 Jun.
Article de Anglais | MEDLINE | ID: mdl-19785919

RÉSUMÉ

BACKGROUND: Attitudes and expectations about treatment have been associated with symptomatic outcomes, adherence and utilization in patients with psychiatric disorders. No measure of patients' anticipated benefits of treatment on domains of everyday functioning has previously been available. METHOD: The Anticipated Benefits of Care (ABC) is a new, 10-item questionnaire used to measure patient expectations about the impact of treatment on domains of everyday functioning. The ABC was collected at baseline in adult out-patients with major depressive disorder (MDD) (n=528), bipolar disorder (n=395) and schizophrenia (n=447) in the Texas Medication Algorithm Project (TMAP). Psychometric properties of the ABC were assessed, and the association of ABC scores with treatment response at 3 months was evaluated. RESULTS: Evaluation of the ABC's internal consistency yielded Cronbach's alpha of 0.90-0.92 for patients across disorders. Factor analysis showed that the ABC was unidimensional for all patients and for patients with each disorder. For patients with MDD, lower anticipated benefits of treatment was associated with less symptom improvement and lower odds of treatment response [odds ratio (OR) 0.72, 95% confidence interval (CI) 0.57-0.87, p=0.0011]. There was no association between ABC and symptom improvement or treatment response for patients with bipolar disorder or schizophrenia, possibly because these patients had modest benefits with treatment. CONCLUSIONS: The ABC is the first self-report that measures patient expectations about the benefits of treatment on everyday functioning, filling an important gap in available assessments of attitudes and expectations about treatment. The ABC is simple, easy to use, and has acceptable psychometric properties for use in research or clinical settings.


Sujet(s)
Trouble bipolaire/traitement médicamenteux , Trouble dépressif majeur/traitement médicamenteux , Objectifs , Psychoanaleptiques/usage thérapeutique , Schizophrénie/traitement médicamenteux , Psychologie des schizophrènes , Enquêtes et questionnaires , Adaptation psychologique , Adulte , Algorithmes , Trouble bipolaire/diagnostic , Trouble bipolaire/économie , Trouble bipolaire/psychologie , Échelle abrégée d'appréciation psychiatrique/statistiques et données numériques , Association thérapeutique , Analyse coût-bénéfice , Trouble dépressif majeur/diagnostic , Trouble dépressif majeur/économie , Trouble dépressif majeur/psychologie , Femelle , Humains , Mâle , Adulte d'âge moyen , Inventaire de personnalité/statistiques et données numériques , Psychométrie , Psychoanaleptiques/économie , Schizophrénie/diagnostic , Schizophrénie/économie , Adaptation sociale , Résultat thérapeutique
3.
J Consult Clin Psychol ; 66(2): 377-84, 1998 Apr.
Article de Anglais | MEDLINE | ID: mdl-9583341

RÉSUMÉ

This study presents 2-year follow-up data of a comparison between complete cognitive-behavioral therapy for depression (CT) and its 2 major components: behavioral activation and behavioral activation with automatic thought modification. Data are reported on 137 participants who were randomly assigned to 1 of these 3 treatments for up to 20 sessions with experienced cognitive-behavioral therapists. Long-term effects of the therapy were evaluated through relapse rates, number of asymptomatic or minimally symptomatic weeks, and survival times at 6-, 12-, 18-, and 24-month follow-ups. CT was no more effective than its components in preventing relapse. Both clinical and theoretical implications of these findings are discussed.


Sujet(s)
Thérapie cognitive/méthodes , Trouble dépressif/thérapie , Adulte , Trouble dépressif/psychologie , Femelle , Études de suivi , Humains , Contrôle interne-externe , Mâle , Évaluation de la personnalité , Récidive , Pensée (activité mentale)
4.
Psychiatr Clin North Am ; 20(2): 337-52, 1997 Jun.
Article de Anglais | MEDLINE | ID: mdl-9196918

RÉSUMÉ

Domestic violence is a serious public health concern in the United States. Despite the serious and often tragically fatal consequences of spousal abuse, we have very little understanding about the root causes of domestic violence. We know even less about providing effective treatments and prevention. In this article, we have discussed some of the more promising individual difference variables that discriminate between violent and nonviolent men. We also have addressed some of the growing research on how violent couples are different from nonviolent ones. Unfortunately, methodologic limitations hamper us from being able to discuss definitive risk factors or predictive variables, but we can speak of factors associated with domestic violence. We also have discussed the importance of attending to important differences among violent men and violent couples. The complexity of battering behavior and battering relationships necessarily points researchers and clinicians toward multifaceted research designs and treatment models. The tragedy of domestic violence demands that science continues to address these crucial unanswered questions.


Sujet(s)
Violence domestique , Affect , Alcoolisme , Colère , Dépression/psychologie , Femelle , Hostilité , Humains , Relations interpersonnelles , Mâle , Troubles de la personnalité/psychologie
5.
J Consult Clin Psychol ; 64(2): 295-304, 1996 Apr.
Article de Anglais | MEDLINE | ID: mdl-8871414

RÉSUMÉ

The purpose of this study was to provide an experimental test of the theory of change put forth by A. T. Beck, A. J. Rush, B. F. Shaw, and G. Emery (1979) to explain the efficacy of cognitive-behavioral therapy (CT) for depression. The comparison involved randomly assigning 150 outpatients with major depression to a treatment focused exclusively on the behavioral activation (BA) component of CT, a treatment that included both BA and the teaching of skills to modify automatic thoughts (AT), but excluding the components of CT focused on core schema, or the full CT treatment. Four experienced cognitive therapists conducted all treatments. Despite excellent adherence to treatment protocols by the therapists, a clear bias favoring CT, and the competent performance of CT, there was no evidence that the complete treatment produced better outcomes, at either the termination of acute treatment or the 6-month follow-up, than either component treatment. Furthermore, both BA and AT treatments were just as effective as CT at altering negative thinking as well as dysfunctional attributional styles. Finally, attributional style was highly predictive of both short- and long-term outcomes in the BA condition, but not in the CT condition.


Sujet(s)
Thérapie cognitive , Trouble dépressif/thérapie , Adulte , Trouble dépressif/diagnostic , Femelle , Études de suivi , Humains , Mâle , Adulte d'âge moyen , Tests psychologiques , Résultat thérapeutique
6.
J Nerv Ment Dis ; 182(5): 290-6, 1994 May.
Article de Anglais | MEDLINE | ID: mdl-10678311

RÉSUMÉ

This article reports on the course of uncomplicated panic disorder and panic with agoraphobia on 309 patients participating in the Harvard/Brown Anxiety Research Project, a prospective longitudinal study of patients with DSM-III-R-defined anxiety disorders. At 1 year, there was a .39 probability of full remission for uncomplicated panic disorder and a .17 probability of full remission for panic disorder with agoraphobia Similar differences in time to remission for these syndromes were still found when criteria for remission were made less stringent. However, even requiring less improvement for remission left a large percentage of subjects in an episode, and for those that remitted, relapse occurred quickly, indicating a chronic and recurrent course of illness. This is the first longitudinal, prospective, naturalistic study on a large cohort of subjects with anxiety disorders to have regular, structured, short-interval follow-up. Our results are consistent with the view that panic disorder has a chronic course with high rates of relapse after remission and longer episodes when agoraphobia is a part of the constellation of symptoms.


Sujet(s)
Agoraphobie/diagnostic , Trouble panique/diagnostic , Adulte , Agoraphobie/épidémiologie , Agoraphobie/thérapie , Maladie chronique , Comorbidité , Femelle , Études de suivi , Humains , Études longitudinales , Mâle , Trouble panique/épidémiologie , Trouble panique/thérapie , Probabilité , Études prospectives , Échelles d'évaluation en psychiatrie/statistiques et données numériques , Psychothérapie , Psychoanaleptiques/usage thérapeutique , Récidive , Indice de gravité de la maladie , Analyse de survie , Résultat thérapeutique
7.
J Nerv Ment Dis ; 182(2): 72-9, 1994 Feb.
Article de Anglais | MEDLINE | ID: mdl-8308535

RÉSUMÉ

In a cross-sectional investigation of the properties of DSM-III-R panic disorder (PD), panic disorder with agoraphobia (PDA), and agoraphobia without history of panic disorder (AWOPD), we analyzed demographic, descriptive, comorbidity, treatment, and course data for 562 subjects with PD, PDA, or AWOPD in a multicenter anxiety-disorders study. In general, AWOPD subjects had the worst functioning and PD subjects the best, as measured by length of intake episodes, education attained, likelihood of receiving financial assistance, depressive comorbidity, and likelihood of having experienced 8 weeks symptom-free. Panic disorder with agoraphobia was the most common disorder and emerged as a condition intermediate in severity between the other two. Treatments received varied little by diagnosis. Most subjects received medication, usually benzodiazepines. Psychodynamic psychotherapy was the most frequently received psychosocial treatment; cognitive and behavioral approaches were less common. Subjects classified with AWOPD were the most likely to have received exposure therapies.


Sujet(s)
Agoraphobie/épidémiologie , Trouble panique/épidémiologie , Adulte , Sujet âgé , Agoraphobie/diagnostic , Agoraphobie/thérapie , Benzodiazépines/usage thérapeutique , Comorbidité , Études transversales , Diagnostic différentiel , Femelle , Études de suivi , Humains , Mâle , Adulte d'âge moyen , Trouble panique/diagnostic , Trouble panique/thérapie , Études prospectives , Échelles d'évaluation en psychiatrie , Psychothérapie , Indice de gravité de la maladie , Résultat thérapeutique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...